CIBA one more-
CIBC To Host Conference Call:
Successes and Failures in Finding a Treatment for
Pulmonary Fibrosis
On Thursday, April 5, at 11 a.m. ET (8 a.m. PT), we will host a conference call with Dr. Ganesh Raghu, chief of the Chest Clinic at the University of Washington Medical Center and a well-known authority in idiopathic pulmonary fibrosis (IPF). Dr. Raghu will discuss his interpretation of the phase III pirfenidone data recently presented by Shionogi, and the implications for InterMune's phase III pirfenidone program. He will also give his thoughts on the potential role of pirfenidone in the future treatment of IPF. Dr. Raghu will review the current therapeutic approaches used in patients with IPF, and how the recent negative data for InterMune's Actimmune is likely to change such practices. He will also provide an overview of other agents currently in development to treat IPF. A Q&A session will follow.
